Association of a TNIP1 polymorphism with vogt-koyanagi-harada syndrome but not with ocular behcet's Disease in Han Chinese

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Shi, Yanyun ^a   Jia, Yading ^b   Hou, Shengping ^a,c,d   Fang, Jing ^a   Zhou, Yan ^a   Kijlstra, Aize ^e   Yang, Peizeng ^a,c,d  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SHANXI EYE HOSPITAL   (China)

^c Chongqing Eye Institute   (China)

^d Chongqing Key Laboratory of Ophthalmology   (China)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TNIP1GENE; UPREGULATION; VOGT KOYANAGI SYNDROME; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MENINGOENCEPHALITIS;

DNA BINDING PROTEIN; TNIP1 PROTEIN, HUMAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BEHCET SYNDROME; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84900454918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095573     Document Type: Article

References (35)

1. Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, et al. (2008) Ubiquitinbinding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745. (Pubitemid 351912974)
2. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
3. He CF, Liu YS, Cheng YL, Gao JP, Pan TM, et al. (2010) TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19:1181-1186.
4. Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, et al. (2010) Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther 12: R174.
5. Zhong H, Li XL, Li M, Hao LX, Chen RW, et al. (2011) Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 13: R186.
6. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199-204.
7. Sun LD, Cheng H, Wang ZX, Zhang AP, Wang PG, et al. (2010) Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 42: 1005-1009.
8. Bowes J, Orozco G, Flynn E, Ho P, Brier R, et al. (2011) Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 70: 1641-1644.
9. Allanore Y, Saad M, Dieudé P, Avouac J, Distler JH, et al. (2011) Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 7: e1002091.
10. Zhang J, Chen Y, Shao Y, Wu Q, Guan M, et al. (2012) Identification of TNIP1 Polymorphisms by High Resolution Melting Analysis with Unlabelled Probe: Association with Systemic Lupus Erythematosus. Autoimmune Dis 2012: 265823.
11. Yang P, Zhang Z, Zhou H, Li B, Huang X, et al. (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30: 943-948. (Pubitemid 43154688)
12. Sakane T, Takeno M, Suzuki N, Inaba GN (1999) Behçet's disease. Engl J Med. 341: 1284-1291.
13. Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH (2009) New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol 72: 413-420.
14. Weisz JM, Holland GN, Roer LN, Park MS, Yuge AJ, et al. (1995) Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology 102: 1012-1015.
15. Arellanes-García L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, et al. (1998) HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 6: 93-100. (Pubitemid 28380073)
16. Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, et al. (2000) Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol 129: 173-177. (Pubitemid 30089276)
17. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A (2009) HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 61: 1287-1296.
18. Jiang Z, Yang P, Hou S, Li F, Zhou H (2010) Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Hum Immunol. 71: 414-417.
19. Kim ES, Kim SW, Moon CM, Park JJ, Kim TI, et al. (2012) Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population. Life Sci 90: 740-746.
20. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, et al. (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci..Nat Genet 42: 703-706.
21. Horie Y, Kitaichi N, Katsuyama Y, Yoshida K, Miura T, et al. (2009) Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 15: 1115-1119.
22. Sahin N, Bicakcigil M, Atagunduz P, Direskeneli H, Saruhan-Direskeneli G (2007) PTPN22 gene polymorphism in Behçet's disease. Tissue Antigens 70: 432-434. (Pubitemid 47537407)
23. Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, et al. (2007) The association of the PTPN22 620W polymorphism with Behcet's disease. Ann Rheum Dis 66: 1531-1533. (Pubitemid 350032665)
24. Yi L, Wang JC, Guo XJ, Gu YH, Tu WZ, et al. (2013) STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. Int J Immunopathol Pharmacol 26: 473-478.
25. Shen L, Liu R, Zhang H, Huang Y, Sun R, et al. (2013) Replication study of STAT4 rs7574865 G/T polymorphism and risk of rheumatoid arthritis in a Chinese population. Gene 526: 259-264
26. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, et al. (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131: 647-652. (Pubitemid 32422124)
27. Mignogna MD, Fedele S, Lo Russo L (2000) International diagnostic criteria and delay of diagnosis in Behcet's disease. J Rheumatol 27: 2725.
28. Bordaberry MF (2010) Vogt-Koyanagi-Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol 21: 430-435.
29. Fang W, Yang P (2008) Vogt-koyanagi-harada syndrome.Curr Eye Res 33: 517-523. (Pubitemid 351948483)
30. Krause I, Weinberger A (2008) Behçet's disease. Curr Opin Rheumatol 20: 82-87.
31. Yuan J, Yu M, Cao AL, Chen X, Zhang LH, et al. (2013) Novel Epitope from CD22 Regulates Th1 and Th17 Cell Function in Systemic Lupus Erythematosus. PLoS One 8: e64572.
32. Hu DN, Chen M, Zhang DY, Ye F, McCormick SA, et al. (2011) Interleukin-1beta increases baseline expression and secretion of interleukin-6 by human uveal melanocytes in vitro via the p38 MAPK/NF-kappaB pathway. Invest Ophthalmol Vis Sci 52: 3767-3774.
33. Ramirez VP, Gurevich I, Aneskievich BJ (2012) Emerging roles for TNIP1 in regulating post-receptor signaling. Cytokine Growth Factor Rev 23: 109-118.
34. Gurevich I, Zhang C, Francis N, Struzynsky CP, Livings SE, et al. (2013) Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors. Gene 515: 42-48.
35. Gurevich I, Zhang C, Encarnacao PC, Struzynski CP, Livings SE, et al. (2012) PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1. Biochim Biophys Acta 1819: 1-15.